Medicinal Products

SODIUM ALGINATE / SODIUM BICARBONATE ZENTIVA 500 mg / 267 mg

Generic drug from Gaviscon
Therapeutic class: Gastro-Entero-Hepatology
Active ingredients: Sodium alginate + Sodium bicarbonate
laboratory: Sanofi-Aventis France

Oral suspension
in sachet box of 24 sachets of 10 ml
All forms

Indication

Symptomatic treatment of gastroesophageal reflux.

Dosage SODIUM ALGINATE / SODIUM BICARBONATE ZENTIVA 500 mg / 267 mg oral suspension in sachets box of 24 sachets of 10 ml

Symptomatic treatment of gastroesophageal reflux.

Against indications

Hypersensitivity to the active substances or to any of the excipients.

Side effects Alginate / bicarb Sodium Zentiva

Related to calcium carbonate:

· Possible constipation, which is exceptional thanks to the presence of alginate.

· In prolonged use, possible hypercalcemia with risk of nephrolithiasis and renal failure.

Allergic manifestations such as urticaria, bronchospasm, anaphylactic or anaphylactoid reactions have been reported.

Reporting of suspected adverse reactions

The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article